Lincluden Management Ltd. bought a new position in GSK plc (NYSE:GSK – Get Rating) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 170,636 shares of the pharmaceutical company’s stock, valued at approximately $5,996,000. Other hedge funds have also added to or reduced their stakes in […]